Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy

Human Molecular Genetics

Volumn 23, Issue 2, 2014, Pages 383-396

  van Ry, Pam M ^a   Minogue, Priscilla ^a   Hodges, Bradley L ^b   Burkin, Dean J ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b Prothelia Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA7BETA1 INTEGRIN; CARDIOTOXIN; INTEGRIN; LAMININ; LAMININ 111; LAMININ ALPHA2; MEROSIN; MYOGENIN; MYOSIN HEAVY CHAIN; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DISEASE SEVERITY; DRUG HALF LIFE; IMMUNOFLUORESCENCE; JOINT CONTRACTURE; MEROSIN DEFICIENT CONGENITAL MUSCULAR DYSTROPHY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOBLAST; MYOTUBE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; TRANSIENT EXPRESSION; WESTERN BLOTTING;

ANIMALS; FIBROSIS; GENE EXPRESSION REGULATION; LAMININ; MICE; MUSCULAR ATROPHY; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; MYOGENIN; PAX7 TRANSCRIPTION FACTOR;

EID: 84893597671     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt428     Document Type: Article

References (47)

1. Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J.,Tomé, F.M., Schwartz, K., Fardeau,M.and Tryggvason, K. (1995) Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet., 11, 216-218.
2. Gawlik, K.I. and Durbeej, M. (2011) Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet. Muscle, 1, 9.
3. Carmignac, V., Svensson, M., Körner, Z., Elowsson, L., Matsumura, C., Gawlik, K.I., Allamand, V. and Durbeej, M. (2011) Autophagy is increased in laminin a2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A. Hum. Mol. Genet., 20, 4891-4902.
4. Jones, K.J., Morgan, G., Johnston, H., Tobias, V., Ouvrier, R.A., Wilkinson, I. and North, K.N. (2001) The expanding phenotype of laminin a2 chain (merosin) abnormalities: case series and review. J. Med. Genet., 38, 649-657.
5. Muntoni, F. and Voit, T. (2004) The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul. Disord., 14, 635-649.
6. Philpot, J., Bagnall, A., King, C., Dubowitz, V. and Muntoni, F. (1999) Feeding problems in merosin deficient congenital muscular dystrophy. Arch. Dis. Child., 80, 542-547.
7. Philpot, J., Cowan, F., Pennock, J., Sewry, C., Dubowitz, V., Bydder, G. and Muntoni, F. (1999) Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul. Disord., 9, 81-85.
8. Mendell, J.R., Boué, D.R. and Martin, P.T. (2006) The congenital muscular dystrophies: recent advances and molecular insights. Pediatr. Dev. Pathol., 9, 427-443.
9. Aumailley, M. and Smyth, N. (1998) The role of laminins in basement membrane function. J. Anat., 193(Pt 1), 1-21.
10. Gawlik, K., Miyagoe-Suzuki, Y., Ekblom, P., Takeda, S. and Durbeej, M. (2004) Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice. Hum. Mol. Genet., 13, 1775-1784.
11. Gawlik, K.I., Akerlund, M., Carmignac, V., Elamaa, H. and Durbeej, M. (2010) Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency. PLoS One, 5, e11549.
12. Gawlik, K.I. and Durbeej, M. (2010) Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan. Muscle Nerve, 42, 30-37.
13. Kuang, W., Xu, H., Vachon, P.H., Liu, L., Loechel, F., Wewer, U.M. and Engvall, E. (1998) Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J. Clin. Invest., 102, 844-852.
14. Bentzinger, C.F., Barzaghi, P., Lin, S. and Ruegg, M.A. (2005). Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB J., 19, 934-942.
15. Meinen, S., Barzaghi, P., Lin, S., Lochmüller, H. and Ruegg, M.A. (2007) Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. J. Cell. Biol., 176, 979-993.
16. W mouse model of congenital muscular dystrophy 1A. Am. J. Pathol., 171, 181-199.
17. Kumar, A., Yamauchi, J., Girgenrath, T. and Girgenrath, M. (2011) Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A. Hum. Mol. Genet., 20, 2333-2343.
18. Doe, J.A., Wuebbles, R.D., Allred, E.T., Rooney, J.E., Elorza, M. and Burkin, D.J. (2011) Transgenic overexpression of the a7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. J. Cell. Sci., 124, 2287-2297.
19. Girgenrath, M., Dominov, J.A., Kostek, C.A. and Miller, J.B. (2004) Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J. Clin. Invest., 114, 1635-1639.
20. Erb, M., Meinen, S., Barzaghi, P., Sumanovski, L.T., Courdier-Früh, I., Rüegg, M.A. and Meier, T. (2009) Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency. J. Pharmacol. Exp. Ther., 331, 787-795.
21. Girgenrath, M., Beermann, M.L., Vishnudas, V.K., Homma, S. and Miller, J.B. (2009) Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann. Neurol., 65, 47-56.
22. Vachon, P.H., Xu, H., Liu, L., Loechel, F., Hayashi, Y., Arahata, K., Reed, J.C., Wewer, U.M. and Engvall, E. (1997) Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest., 100, 1870-1881.
23. Rooney, J.E., Knapp, J.R., Hodges, B.L., Wuebbles, R.D. and Burkin, D.J. (2012) Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy. Am. J. Pathol., 180, 1593-1602.
24. Rooney, J.E., Gurpur, P.B., Yablonka-Reuveni, Z. and Burkin, D.J. (2009) Am. J. Pathol., 174, 256-264.
25. Welser, J.V., Rooney, J.E., Cohen, N.C., Gurpur, P.B., Singer, C.A., Evans, R.A., Haines, B.A. and Burkin, D.J. (2009) Am. J. Pathol., 175, 1545-1554.
26. Burkin, D.J., Wallace, G.Q., Milner, D.J., Chaney, E.J., Mulligan, J.A. and Kaufman, S.J. (2005) Am. J. Pathol., 166, 253-263.
27. Hodges, B.L., Hayashi, Y.K., Nonaka, I., Wang, W., Arahata, K. and Kaufman, S.J. (1997) Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J. Cell. Sci., 110(Pt 22), 2873-2881.
28. Peat, R.A., Smith, J.M., Compton, A.G., Baker, N.L., Pace, R.A., Burkin, D.J., Kaufman, S.J., Lamandé, S.R. and North, K.N. (2008) Diagnosis and etiology of congenital muscular dystrophy. Neurology, 71, 312-321.
29. Marshall, J.L. and Crosbie-Watson, R.H. (2013) Sarcospan: a small protein with large potential for Duchenne muscular dystrophy. Skelet. Muscle, 3, 1.
30. Marshall, J.L., Chou, E., Oh, J., Kwok, A., Burkin, D.J. and Crosbie-Watson, R.H. (2012) Dystrophin and utrophin expression require sarcospan: loss of a7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. Hum. Mol. Genet., 21, 4378-4393.
31. Gawlik, K.I., Mayer, U., Blomberg, K., Sonnenberg, A., Ekblom, P. and Durbeej, M. (2006) Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan. FEBS Lett., 580, 1759-1765.
32. Lorts, A., Schwanekamp, J.A., Baudino, T.A., McNally, E.M. and Molkentin, J.D. (2012) Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-b pathway. Proc. Natl. Acad. Sci. U S A, 109, 10978-10983.
33. Murphy, M.M., Lawson, J.A., Mathew, S.J., Hutcheson, D.A. and Kardon, G. (2011) Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development, 138, 3625-3637.
34. Veidal, S.S., Karsdal, M.A., Nawrocki, A., Larsen, M.R., Dai, Y., Zheng, Q., Hägglund, P., Vainer, B., Skjø t-Arkil, H. and Leeming, D.J. (2011) Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis. Fibrogenesis Tissue Repair, 4, 22.
35. Chargé, S.B. and Rudnicki, M.A. (2004) Cellular and molecular regulation of muscle regeneration. Physiol. Rev., 84, 209-238.
36. Hawke, T.J. and Garry, D.J. (2001) Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol., 91, 534-551.
37. Schultz, E., Chamberlain, C., McCormick, K.M. and Mozdziak, P.E. (2006) Satellite cells express distinct patterns of myogenic proteins in immature skeletal muscle. Dev. Dyn., 235, 3230-3239.
38. Kuang, W., Xu, H., Vilquin, J.T. and Engvall, E. (1999) Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency. Lab. Invest., 79, 1601-1613.
39. Taniguchi, Y., Ido, H., Sanzen, N., Hayashi, M., Sato-Nishiuchi, R., Futaki, S. and Sekiguchi, K. (2009) The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. J. Biol. Chem., 284, 7820-7831.
40. Nishiuchi, R., Takagi, J., Hayashi, M., Ido, H., Yagi, Y., Sanzen, N., Tsuji, T., Yamada, M. and Sekiguchi, K. (2006) Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix. Biol., 25, 189-197.
41. Talts, J.F., Andac, Z., Göhring, W., Brancaccio, A. and Timpl, R. (1999) Binding of the G domains of laminin a1 and a2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J., 18, 863-870.
42. Yamada, H., Shimizu, T., Tanaka, T., Campbell, K.P. and Matsumura, K. (1994) Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett., 352, 49-53.
43. Meinen, S., Lin, S., Thurnherr, R., Erb, M., Meier, T. and Rüegg, M.A. (2011) Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice. EMBO Mol. Med., 3, 465-479.
44. Yajima, H., Motohashi, N., Ono, Y., Sato, S., Ikeda, K., Masuda, S., Yada, E., Kanesaki, H., Miyagoe-Suzuki, Y., Takeda, S. et al. (2010) Six family genes control the proliferation and differentiation of muscle satellite cells. Exp. Cell. Res., 316, 2932-2944.
45. Kuang, S., Chargé, S.B., Seale, P., Huh, M. and Rudnicki, M.A. (2006) Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J. Cell. Biol., 172, 103-113.
46. Landis, S.C., Amara, S.G., Asadullah, K., Austin, C.P., Blumenstein, R., Bradley, E.W., Crystal, R.G., Darnell, R.B., Ferrante, R.J., Fillit, H. et al. (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature, 490, 187-191.
47. Junqueira, L.C., Bignolas, G. and Brentani, R.R. (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J., 11, 447-455.